ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AG9. A total of 19 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fore Research & Management, LP | 45,073,000 | $109,189,000 | 3.21% |
| WHITEBOX ADVISORS LLC | 18,228,000 | $44,066,000 | 1.71% |
| Nantahala Capital Management | 5,650,000 | $13,765,000 | 1.69% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 5,800,000 | $14,022,000 | 1.43% |
| WOLVERINE ASSET MANAGEMENT LLC | 25,720,000 | $62,292,000 | 1.30% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 13,000,000 | $31,560,000 | 0.36% |
| CSS LLC/IL | 2,534,000 | $6,139,000 | 0.30% |
| LORD, ABBETT & CO. LLC | 17,349,000 | $42,028,000 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,300,000 | $3,153,000 | 0.08% |
| Citadel Advisors | 24,500,000 | $59,352,000 | 0.06% |